Batya Davidovici
Ben-Gurion University of the Negev
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Batya Davidovici.
British Journal of Dermatology | 2007
S. H. Kardaun; A. Sidoroff; L. Valeyrie-Allanore; Sima Halevy; Batya Davidovici; M. Mockenhaupt; Jean-Claude Roujeau
ulceration. Dis Colon Rectum 2005; 48:1442–6. 4 Egred M, Andron M, Morrison WL. Nicorandil may be associated with gastrointestinal ulceration. BMJ 2006; 332:889. 5 King PM, Suttie SA, Jansen JO, Watson AJM. Perforation of the terminal ileum: a possible complication of nicorandil therapy. Surgeon 2004; 2:56–7. 6 Watson A, Al-Ozairi O, Fraser A et al. Nicorandil associated anal ulceration. Lancet 2002; 360:546–7.
Journal of Burn Care & Research | 2011
Peggy Sekula; Yvonne Liss; Batya Davidovici; Ariane Dunant; Jean-Claude Roujeau; Sylvia H. Kardaun; Luigi Naldi; Martin Schumacher; Maja Mockenhaupt
The purpose of this study was to evaluate the severity-of-illness score called SCORTEN with respect to its predictive ability and by using data obtained in the RegiSCAR study, the most comprehensive European registry of patients with Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). For advanced comparisons, an auxiliary score (AS) was defined using data obtained in a previous study. Three hundred sixty-nine patients with SJS/TEN were included in RegiSCAR between 2003 and 2005. The data needed for calculation of SCORTEN were available for 45% of patients. The score revealed a moderate predictive ability with a slight underestimation of the total number of in-hospital deaths by 11%, an area under the receiver operating characteristic curve of 0.75, and a Brier score of 0.14. Problems could be seen by analyzing subgroups such as patients with TEN. The AS was better calibrated but discriminated worse (area under the receiver operating characteristic curve: 0.72; Brier score: 0.14). With the help of a refined score derived from SCORTEN and AS, potential for a possible improvement could be demonstrated. The authors were able to show that the predictive ability of SCORTEN is acceptable. Although improvement might be possible, SCORTEN remains the tool of choice, whereas AS might be an alternative in retrospective settings with missing laboratory data.
British Journal of Dermatology | 2010
Sima Halevy; Sylvia H. Kardaun; Batya Davidovici; J. Wechsler
Background Acute generalized exanthematous pustulosis (AGEP) is a rare severe pustular reaction pattern with a typical clinical picture.
Archives of Pathology & Laboratory Medicine | 2000
Samuel Ariad; Daniel Benharroch; Lilliana Lupu; Batya Davidovici; Nicolas Dupin; Chris Boshoff
Human herpesvirus 8 (HHV-8), or Kaposi sarcoma-associated herpesvirus, is a gamma herpesvirus first detected in a specimen of Kaposi sarcoma from a human immunodeficiency virus (HIV)-positive patient. Human herpesvirus 8 is also found in an unusual clinicopathologic form of body cavity-based B-cell lymphoma, which has been named primary effusion lymphoma (PEL) and occurs primarily in HIV-positive patients. PEL is characterized by the formation of lymphomatous effusions, without obvious lymphadenopathy, tumor masses, or bone marrow involvement. Only a few cases of PEL in HIV-seronegative patients have been reported. We describe a case of an HHV-8-associated lymphoma, with ascites, pleural effusion, and axillary lymphadenopathy in an HIV-negative patient. The patient was a 68-year-old Jewish man of North African extraction, with a previous history of coronary bypass surgery and multiple blood transfusions. The pleural fluid contained large atypical lymphoid cells and was suggestive of lymphoma but could not provide a conclusive diagnosis of PEL. The lymph node contained groups of large anaplastic lymphoid cells. Polymerase chain reaction for HHV-8 performed on the lymph node specimen was positive, establishing the diagnosis of PEL. Polymerase chain reaction for Epstein-Barr virus was negative. Results of a gallium scan were normal. The patient did not respond to combination chemotherapy with cyclophosphamide, doxorubicin, vincristine sulfate, and prednisone and progressively developed, massive intra-abdominal solid tumor formation. To our knowledge, this is the first report of a case of PEL that demonstrates peripheral lymph node involvement at diagnosis and the first report of PEL in an Israeli patient.
Radiotherapy and Oncology | 2008
Laurence Valeyrie-Allanore; Nicolas Poulalhon; Jean-Paul Fagot; Peggy Sekula; Batya Davidovici; Alexis Sidoroff; Maja Mockenhaupt
Amifostine is an organic thiophosphate prodrug used for cytoprotection against toxic effects of radiotherapy and chemotherapy. In a European prospective study of SJS/TEN, six patients were suspected to have SJS/TEN associated with amifostine. Our findings suggest that the risk of life-threatening cutaneous adverse reactions to amifostine could be significantly increased.
British Journal of Dermatology | 2010
Sima Halevy; Sylvia H. Kardaun; Batya Davidovici; J. Wechsler
Background Acute generalized exanthematous pustulosis (AGEP) is a rare severe pustular reaction pattern with a typical clinical picture.
Journal of the National Cancer Institute | 2001
Batya Davidovici; Isabella Karakis; Dimitra Bourboulia; Samuel Ariad; Jian Chao Zong; Daniel Benharroch; Nicolas Dupin; Robin A. Weiss; Gary S. Hayward; Batia Sarov; Chris Boshoff
Journal of The American Academy of Dermatology | 2006
Batya Davidovici; Dyachenko Pavel; Emanuela Cagnano; Dganit Rozenman; Sima Halevy
Israel Medical Association Journal | 2008
Batya Davidovici; Roni P. Dodiuk-Gad; Dganit Rozenman; Sima Halevy
Israel Medical Association Journal | 2008
Avner Shemer; Henri Trau; Batya Davidovici; Boaz Amichai; Marcelo H. Grunwald